188 related articles for article (PubMed ID: 24403837)
1. Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma.
Feng JF; Huang Y; Liu JS
Onco Targets Ther; 2013; 6():1605-12. PubMed ID: 24403837
[TBL] [Abstract][Full Text] [Related]
2. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma.
Feng JF; Huang Y; Chen QX
World J Surg Oncol; 2014 Mar; 12():58. PubMed ID: 24641770
[TBL] [Abstract][Full Text] [Related]
3. Combined neutrophil-platelet score and hemoglobin level predict survival in esophageal squamous cell carcinoma patients treated with chemoradiotherapy.
Miao C; Zhu S; Pan H; Cao X; Yuan S; Hu X
Oncotarget; 2017 Oct; 8(50):87971-87979. PubMed ID: 29152134
[TBL] [Abstract][Full Text] [Related]
4. Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma.
Chen K; Zhan MX; Hu BS; Li Y; He X; Fu SR; Xin YJ; Lu LG
Oncol Lett; 2018 Jan; 15(1):315-323. PubMed ID: 29285194
[TBL] [Abstract][Full Text] [Related]
5. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
6. The Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Predicts Disease-Free Survival in Resectable Esophageal Squamous Cell Carcinoma.
Zheng Z; Yang C; Cai C; Zhu H
Cancer Manag Res; 2021; 13():7511-7516. PubMed ID: 34621132
[TBL] [Abstract][Full Text] [Related]
7. Platelet-to-lymphocyte ratio is an independent prognosticator in patients with esophageal squamous cell carcinoma receiving esophagectomy.
Chen LC; Li SH; Lo CM; Chen YH; Huang SC; Wang YM; Chou SY; Lu HI
J Thorac Dis; 2019 Nov; 11(11):4583-4590. PubMed ID: 31903247
[TBL] [Abstract][Full Text] [Related]
8. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma.
Gao Y; Guo W; Cai S; Zhang F; Shao F; Zhang G; Liu T; Tan F; Li N; Xue Q; Gao S; He J
J Cancer; 2019; 10(14):3188-3196. PubMed ID: 31289589
[No Abstract] [Full Text] [Related]
9. Combined Use of the Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as a Prognostic Predictor in Patients with Operable Soft Tissue Sarcoma.
Liang Y; Wang W; Li J; Guan Y; Que Y; Xiao W; Zhang X; Zhou Z
J Cancer; 2018; 9(12):2132-2139. PubMed ID: 29937932
[No Abstract] [Full Text] [Related]
10. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation.
He YF; Luo HQ; Wang W; Chen J; Yao YW; Yan Y; Wu SS; Hu XX; Ke LH; Niu JY; Li HM; Ji CS; Hu B
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26947428
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
Xie X; Luo KJ; Hu Y; Wang JY; Chen J
Dis Esophagus; 2016 Jan; 29(1):79-85. PubMed ID: 25410116
[TBL] [Abstract][Full Text] [Related]
12. The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis.
Sun Y; Zhang L
Cancer Manag Res; 2018; 10():6167-6179. PubMed ID: 30538564
[TBL] [Abstract][Full Text] [Related]
13. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment NRS-2002 scores combined with hematologic inflammation markers are independent prognostic factors in patients with resectable thoracic esophageal squamous cell carcinoma.
Guo XW; Liu YC; Gao F; Ji SJ; Zhou JY; Ji L; Zhou SB
Cancer Manag Res; 2018; 10():2409-2418. PubMed ID: 30122990
[TBL] [Abstract][Full Text] [Related]
15. The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy.
Gao QF; Qiu JC; Huang XH; Xu YM; Li SQ; Sun F; Zhang J; Yang WM; Min QH; Jiang YH; Chen QG; Zhang L; Wang XZ; Ying HQ
Cancer Cell Int; 2018; 18():153. PubMed ID: 30305803
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma.
Zhu S; Miao CW; Wang ZT; Peng L; Li B
Onco Targets Ther; 2016; 9():6187-6193. PubMed ID: 27789959
[TBL] [Abstract][Full Text] [Related]
17. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.
Wu G; Yao Y; Bai C; Zeng J; Shi D; Gu X; Shi X; Song Y
Thorac Cancer; 2015 May; 6(3):275-87. PubMed ID: 26273373
[TBL] [Abstract][Full Text] [Related]
18. The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?
Chen S; Guo J; Feng C; Ke Z; Chen L; Pan Y
Ther Adv Med Oncol; 2016 May; 8(3):160-7. PubMed ID: 27239234
[TBL] [Abstract][Full Text] [Related]
19. Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma.
Wu X; Han R; Zhong Y; Weng N; Zhang A
Cancer Cell Int; 2021 Jul; 21(1):356. PubMed ID: 34233686
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
Jung J; Park SY; Park SJ; Park J
Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
